The diagnosis of SARS-CoV-2 infection is made by detection by RT-PCR of viral genetic material; however, some countries (especially in the Latin American region), may be limited in the ability to carry out a certain diagnosis, as well as follow-up of cases, due to the limitation of access to reagents, which can be added to economic resources (countries dependent on crude oil prices, for example).
We know that we could be under-diagnosed?
So which do you think colleagues?
What should be the action from public health?
Do we limit testing to patients with severe or severe COVID-19?
How to establish measures to contain the infection?